CANNABINOID DERIVATIVES AS PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHOD OF PREPARATION THEREOF
The present invention relates to a group of novel compounds, methods for their manufacture and the use of these compounds as research tools and as pharmaceuticals. The novel compounds are analogues of cannabidiol (CBD). CBD is a non-psychoactive cannabinoid which has been used to treat various diseases and disorders. While such treatments hold promise, there remains a need in the art for more effective treatments and this has been brought about by way of novel cannabidiol compounds..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Europäisches Patentamt - (2023) vom: 25. Okt. Zur Gesamtaufnahme - year:2023 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
SILCOCK ALAN JAMES [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-10-25, Last update posted on www.tib.eu: 2024-02-27, Last updated: 2024-03-01 |
---|
Patentnummer: |
EP4262980 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA018329799 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | EPA018329799 | ||
003 | DE-627 | ||
005 | 20240301101016.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231103s2023 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA018329799 | ||
035 | |a (EPA)EP4262980 | ||
035 | |a (EPA)85460231 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a SILCOCK ALAN JAMES |e verfasserin |4 aut | |
245 | 1 | 0 | |a CANNABINOID DERIVATIVES AS PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHOD OF PREPARATION THEREOF |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2023-10-25, Last update posted on www.tib.eu: 2024-02-27, Last updated: 2024-03-01 | ||
520 | |a The present invention relates to a group of novel compounds, methods for their manufacture and the use of these compounds as research tools and as pharmaceuticals. The novel compounds are analogues of cannabidiol (CBD). CBD is a non-psychoactive cannabinoid which has been used to treat various diseases and disorders. While such treatments hold promise, there remains a need in the art for more effective treatments and this has been brought about by way of novel cannabidiol compounds. | ||
650 | 4 | |a C07D: Heterocyclic compounds (macromolecular compounds c08) | |
650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
650 | 4 | |a che | |
650 | 4 | |a C07C: Acyclic or carbocyclic compounds (macromolecular compounds c08;production of organic compounds by electrolysis or electrophoresis c25b0003000000, c25b0007000000) | |
650 | 4 | |a 615 | |
700 | 0 | |a MILLET ANTOINE |4 aut | |
700 | 0 | |a TSE KAREN KA-YEN |4 aut | |
700 | 0 | |a HINCHLIFFE PAUL STUART |4 aut | |
700 | 0 | |a SHARPE ANDREW |4 aut | |
700 | 0 | |a SIMPSON IAIN DAVID |4 aut | |
700 | 0 | |a PEACH JOANNE |4 aut | |
700 | 0 | |a LEVANTO STEFANO |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 25. Okt. |
773 | 1 | 8 | |g year:2023 |g day:25 |g month:10 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/85460231/publication/EP4262980A1?q=EP4262980 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
951 | |a AR | ||
952 | |j 2023 |b 25 |c 10 |